| 中文名 | 5-氨基-3-(三氟甲基)氰基吡啶 |
|---|---|
| 英文名 | 5-amino-3-(trifluoromethyl)pyridine-2-carbonitrile |
| 中文别名 | 5-氨基-3-三氟甲基-2-氰基吡啶 |
| 英文别名 |
5-Amino-3-(trifluoromethyl)-2-pyridinecarbonitrile
5-Amino-2-cyano-3-trifluoromethylpyridine 2-Pyridinecarbonitrile, 5-amino-3-(trifluoromethyl)- QC-4621 |
| 密度 | 1.5±0.1 g/cm3 |
|---|---|
| 沸点 | 362.2±42.0 °C at 760 mmHg |
| 分子式 | C7H4F3N3 |
| 分子量 | 187.122 |
| 闪点 | 172.8±27.9 °C |
| 精确质量 | 187.035736 |
| PSA | 62.70000 |
| LogP | 2.72 |
| 蒸汽压 | 0.0±0.8 mmHg at 25°C |
| 折射率 | 1.498 |
| 储存条件 | 2-8°C |
| 危害码 (欧洲) | T+ |
|---|---|
| 危险品运输编码 | 3439.0 |
| 海关编码 | 2933399090 |
|
~85%
573762-62-6 |
| 文献:SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH Patent: WO2008/119015 A2, 2008 ; Location in patent: Page/Page column 51 ; |
|
~65%
573762-62-6 |
| 文献:SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH Patent: WO2008/119015 A2, 2008 ; Location in patent: Page/Page column 47-48 ; |
|
~%
573762-62-6 |
| 文献:ARAGON PHARMACEUTICALS, INC.; SMITH, Nicholas, D.; BONNEFOUS, Celine; JULIEN, Jackaline, D. Patent: WO2011/103202 A2, 2011 ; WO 2011/103202 A2 |
|
~%
573762-62-6 |
| 文献:ARAGON PHARMACEUTICALS, INC.; SMITH, Nicholas, D.; BONNEFOUS, Celine; JULIEN, Jackaline, D. Patent: WO2011/103202 A2, 2011 ; WO 2011/103202 A2 |
|
~%
573762-62-6 |
| 文献:ARAGON PHARMACEUTICALS, INC.; SMITH, Nicholas, D.; BONNEFOUS, Celine; JULIEN, Jackaline, D. Patent: WO2011/103202 A2, 2011 ; WO 2011/103202 A2 |
| 上游产品 3 | |
|---|---|
| 下游产品 1 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |